Keros Therapeutics Inc (KROS)
49.11
-2.00
(-3.91%)
USD |
NASDAQ |
May 23, 16:00
49.11
0.00 (0.00%)
After-Hours: 20:00
Keros Therapeutics Market Cap: 1.772B for May 23, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 22, 2024 | 1.844B |
| May 21, 2024 | 1.820B |
| May 20, 2024 | 1.890B |
| May 17, 2024 | 1.886B |
| May 16, 2024 | 1.948B |
| May 15, 2024 | 1.963B |
| May 14, 2024 | 1.905B |
| May 13, 2024 | 1.949B |
| May 10, 2024 | 1.958B |
| May 09, 2024 | 2.078B |
| May 08, 2024 | 2.102B |
| May 07, 2024 | 2.117B |
| May 06, 2024 | 2.174B |
| May 03, 2024 | 2.186B |
| May 02, 2024 | 2.060B |
| May 01, 2024 | 2.083B |
| April 30, 2024 | 2.034B |
| April 29, 2024 | 2.114B |
| April 26, 2024 | 2.087B |
| April 25, 2024 | 1.955B |
| April 24, 2024 | 2.028B |
| April 23, 2024 | 1.991B |
| April 22, 2024 | 2.012B |
| April 19, 2024 | 2.102B |
| April 18, 2024 | 2.126B |
| Date | Value |
|---|---|
| April 17, 2024 | 2.138B |
| April 16, 2024 | 2.092B |
| April 15, 2024 | 2.080B |
| April 12, 2024 | 2.114B |
| April 11, 2024 | 2.233B |
| April 10, 2024 | 2.194B |
| April 09, 2024 | 2.301B |
| April 08, 2024 | 2.279B |
| April 05, 2024 | 2.260B |
| April 04, 2024 | 2.226B |
| April 03, 2024 | 2.308B |
| April 02, 2024 | 2.309B |
| April 01, 2024 | 2.413B |
| March 28, 2024 | 2.382B |
| March 27, 2024 | 2.327B |
| March 26, 2024 | 2.379B |
| March 25, 2024 | 2.384B |
| March 22, 2024 | 2.370B |
| March 21, 2024 | 2.484B |
| March 20, 2024 | 2.406B |
| March 19, 2024 | 2.310B |
| March 18, 2024 | 2.298B |
| March 15, 2024 | 2.423B |
| March 14, 2024 | 2.333B |
| March 13, 2024 | 2.435B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
385.32M
Minimum
Apr 08 2020
2.536B
Maximum
Mar 08 2024
1.210B
Average
1.190B
Median
Jul 12 2023
Market Cap Benchmarks
| Morphic Holding Inc | 1.392B |
| NovaBay Pharmaceuticals Inc | 5.304M |
| Palatin Technologies Inc | 31.79M |
| iBio Inc | 18.89M |
| Theriva Biologics Inc | 5.912M |
Market Cap Related Metrics
| PEG Ratio | -0.5594 |
| Price to Book Value | 3.904 |
| Price | 49.11 |
| Earnings Yield | -10.49% |
| PEGY Ratio | -0.5594 |